I'l keep an eye out for INSG (has done well for you I see).
I'm in another bio (the one that Baker Brothers bought when they sold 7 mill AMRN - some months ago) - IFRX that has actually done very well also (were in +50 some 1- 1½ year ago) - so is might have real potential (if/when the drug hits the market).
Thanks for your answer - and ATB - with future investments !
We still need all the luck we can get for Amarin to ever 'take of' as it should :)